Fennec Pharmaceuticals (NASDAQ:FENC – Free Report) had its price objective trimmed by HC Wainwright from $18.00 to $17.00 in a research report report published on Friday, Marketbeat Ratings reports. The brokerage currently has a buy rating on the stock. Separately, Cantor Fitzgerald raised their price target on Fennec Pharmaceuticals from $12.00 to $16.00 and gave […]
Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) had its price target increased by Cantor Fitzgerald from $12.00 to $16.00 in a research note issued to investors on Thursday, The Fly reports. They currently have an overweight rating on the stock. Separately, HC Wainwright reaffirmed a buy rating and set a $18.00 target price on shares of […]
Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) had its price objective hoisted by investment analysts at Cantor Fitzgerald from $12.00 to $16.00 in a research report issued on Thursday, The Fly reports. Cantor Fitzgerald’s target price points to a potential upside of 88.68% from the company’s current price. Separately, HC Wainwright restated a “buy” rating and […]
HC Wainwright reissued their buy rating on shares of Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) in a report released on Friday morning, Benzinga reports. They currently have a $18.00 target price on the stock. HC Wainwright also issued estimates for Fennec Pharmaceuticals’ Q1 2024 earnings at $0.03 EPS, Q2 2024 earnings at $0.10 EPS, Q3 […]
HC Wainwright reissued their buy rating on shares of Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) in a report published on Friday morning, Benzinga reports. HC Wainwright currently has a $18.00 target price on the stock. HC Wainwright also issued estimates for Fennec Pharmaceuticals’ Q1 2024 earnings at $0.03 EPS, Q2 2024 earnings at $0.10 EPS, […]